HeyJaredShrabasti Bhattacharya
- Indexed articles, last 90 days
- 20
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 9, 2026
Latest articles
Patients With IBD Face Long-Term Psychiatric Burden (opens the original)
Read excerpt
Among patients with inflammatory bowel disease (IBD), the risk for psychiatric disorders increased 2-3 years before diagnosis, peaked shortly after diagnosis, and remained elevated even at 10 years, according to a recent nationwide cohort study. The increased risk was mainly driven by major depressive disorder, anxiety disorders, and substance misuse. “Health care providers (eg, gastroenterologists and general practitioners) should maintain vigilance for psychiatric symptoms in patients with IBD
Methotrexate for IBD: How Do GIs Use It? (opens the original)
Read excerpt
A new real-world cohort study of more than 1100 patients with inflammatory bowel disease (IBD) provided important evidence on methotrexate use outside clinical trials, showing that it was prescribed predominantly as combination therapy with biologics and had a median treatment duration of approximately 1 year. Although adverse events were reported by a notable proportion of patients, serious toxicity was uncommon. “This study has described for the first time the use of methotrexate in a large co
Early Remdesivir May Protect Kidney Grafts After COVID (opens the original)
Read excerpt
Early remdesivir treatment was associated with a 47% lower risk for all-cause graft loss and a 42% lower risk for cardiovascular events in kidney transplant recipients with COVID. “These findings support guideline recommendations for early antiviral therapy in high-risk populations and suggest that prompt initiation of remdesivir may protect both kidney allografts and cardiovascular health in [kidney transplant] recipients with COVID-19,” the authors of the study wrote. The study was led by Kara
Surgery Underused in Primary Hyperparathyroidism Care (opens the original)
Read excerpt
In a large national cohort, researchers found that end-organ damage from primary hyperparathyroidism was more common than previously reported, affecting 51% of patients at diagnosis and a further 32% of those without baseline damage during follow-up; however, parathyroidectomy remained uncommon despite most patients meeting guideline criteria for surgery. “The high prevalence of [primary hyperparathyroidism]-associated morbidity found in this national population calls for increased attention to
CGM Metrics Can Improve Prognosis Insights Beyond A1c in T1D (opens the original)
Read excerpt
In patients with type 1 diabetes (T1D), continuous glucose monitoring (CGM) hypoglycemic and glycemic variability metrics were associated with the risk for severe hypoglycemia independent of A1c in a pooled analysis. In addition, time in range (TIR) and glycemic variability provided additional information on the risk for diabetic ketoacidosis (DKA) beyond A1c. “[The study] findings highlight the value of CGM for risk assessment and its complementary nature to [A1c] in monitoring T1D,” the author
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.